Capsaicin 0.04% cutaneous patch, Qutenza 179 mg cutaneous patch clinical trials

A randomized, double-blind, placebo-controlled study to assess the effects of high concentration capsaicin patch (Qutenza) on neuropathic symptoms, nerve fibers, and microcirculation in painful diabetic peripheral neuropathy

This study looks at a patch for painful nerve damage caused by diabetes. It checks if using the patch, called Qutenza, helps reduce pain and improves nerve health compared to a dummy patch. We want to see how it affects tiny nerves and blood flow.